Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutation.
Ribeiro Guerra M, Coignard J, Eon-Marchais S, Dondon MG, Le Gal D, Beauvallet J, Mebirouk N, Belotti M, Caron O, Gauthier-Villars M, Coupier I, Buecher B, Lortholary A, Fricker JP, Gesta P, Noguès C, Faivre L, Berthet P, Luporsi E, Delnatte C, Bonadona V, Maugard CM, Pujol P, Lasset C, Longy M, Bignon YJ, Adenis-Lavignasse C, Venat-Bouvet L, Dreyfus H, Gladieff L, Mortemousque I, Audebert-Bellanger S, Soubrier F, Giraud S, Lejeune-Dumoulin S, Limacher JM, Chiesa J, Fajac A, Floquet A, Eisinger F, Tinat J, Fert-Ferrer S, Colas C, Frebourg T, Damiola F, Barjhoux L, Cavaciuti E, Mazoyer S, Tardivon A, Lesueur F, Stoppa-Lyonnet D, Andrieu N. Ribeiro Guerra M, et al. Among authors: maugard cm. Breast Cancer Res. 2021 Aug 3;23(1):79. doi: 10.1186/s13058-021-01456-1. Breast Cancer Res. 2021. PMID: 34344426 Free PMC article.
BRCA2 mutations in hereditary breast and ovarian cancer in France.
Serova-Sinilnikova OM, Boutrand L, Stoppa-Lyonnet D, Bressac-de-Paillerets B, Dubois V, Lasset C, Janin N, Bignon YJ, Longy M, Maugard C, Lidereau R, Leroux D, Frebourg T, Mazoyer S, Lenoir GM. Serova-Sinilnikova OM, et al. Am J Hum Genet. 1997 May;60(5):1236-9. Am J Hum Genet. 1997. PMID: 9150172 Free PMC article. No abstract available.
Marker segregation information in breast/ovarian cancer genetic counseling: is it still useful? Groupe Génétique et Cancer de la Fédération Nationale des Centres de Lutte Contre le Cancer.
Essioux L, Girodet C, Sinilnikova O, Pagès S, Eisinger F, de Résende S, Maugard C, Lanoë D, Longy M, Bignon YJ, Sobol H, Bonaïti-Pellié C, Stoppa-Lyonnet D. Essioux L, et al. Am J Med Genet. 1998 Sep 23;79(3):175-83. doi: 10.1002/(sici)1096-8628(19980923)79:3<175::aid-ajmg5>3.0.co;2-m. Am J Med Genet. 1998. PMID: 9788557
Cancer genetic clinics: why do women who already have cancer attend?
Julian-Reynier C, Eisinger F, Chabal F, Aurran Y, Bignon YJ, Noguès C, Machelard M, Maugard C, Vennin P, Sobol H. Julian-Reynier C, et al. Eur J Cancer. 1998 Sep;34(10):1549-53. doi: 10.1016/s0959-8049(98)00164-6. Eur J Cancer. 1998. PMID: 9893626
Genetic alterations in early-onset invasive breast carcinomas: correlation of c-erbB-2 amplification detected by fluorescence in situ hybridization with p53 accumulation and tumor phenotype.
Fiche M, Avet-Loiseau H, Heymann MF, Moussaly F, Digabel C, Joubert M, Classe JM, Dravet F, Fumoleau P, Ross J, Maugard CM. Fiche M, et al. Among authors: maugard cm. Int J Cancer. 1999 Oct 22;84(5):511-5. doi: 10.1002/(sici)1097-0215(19991022)84:5<511::aid-ijc11>3.0.co;2-5. Int J Cancer. 1999. PMID: 10502729 Free article.
89 results